So much for todays " break through ANNOUNCEMENT " !!
Some might see this as a good thing. Well done Truscreen.
GENERAL: TRU: TruScreen - Commercial Breakthrough in Saudi Arabia
NZX/ASX Announcement
18 September 2023
Commercial breakthrough in Saudi Arabia - commences use of TruScreen technology
TruScreen Group Limited (NZX/ASX:TRU) is pleased to report that the Dr Sulaiman Al-Habib Medical Group, has installed the first tranche of four TruScreen devices for commercial use, for the screening of cervical cancer in Saudi Arabia.
Dr Sulaiman Al-Habib Medical Group (DSAMG) is the largest private hospital network in the Middle East. The adoption of TruScreen's screening technology by DSAMG private hospitals will be important reference sites for further market access in neighbouring Middle Eastern nations.
This installation follows from the previously announced successful completion of the clinical evaluation by DSAMG network, followed by a successful tender by BettaLife Trading FZC (BettaLife) (Truescreen's distributor in the Middle East).
The excellent clinical results of the evaluation were announced previously: see link
https://www.nzx.com/announcements/408275
TruScreen's CEO, Dr Beata Edling said:
"I am very pleased that the Dr Sulaiman Al-Habib Medical Group have approved and will use TruScreen technology to advance the screening for cervical cancer in their hospital network. We congratulate BettaLife, our partner in Saudi Arabia, on reaching this important milestone which will support the expansion of the TruScreen operations in the Middle East."
One of the companies that you really hope are successful given the field they are in and for the betterment of human health (like PEB). But are extremely hard to invest in given their fundamentals and long road to get to market and financial success (like PEB).
Last edited by Sideshow Bob; 13-10-2023 at 12:29 PM.
This ain't a company its a charity. Good cause but numbers are impossible to make work. Same stuff every year since 2014... more losses than revenue after all this time.
"Revenue from sale of goods increased by 33% over the same period prior year to $0.98 million. The Company reported an operating loss of $1.35 million (1H FY22: $1.22 million)."
"As at 30 September 2023, the Company had cash and cash equivalents of $0.8 million."
"At the August 2023 Annual General we indicated to shareholders that further growth funding is required to maintain the commercialisation momentum that we have generated over the past year."
Last edited by silverblizzard888; 06-11-2023 at 08:51 AM.
Bookmarks